ACCURAY WKN: A0MKWM ISIN: US0043971052 Kürzel: XEJ Forum: Aktien Thema: Hauptdiskussion
1,785 EUR
+0,85 %+0,015
23. Dec, 19:17:40 Uhr,
Lang & Schwarz
Kommentare 259
MrTraxxas,
14.07.2022 11:31 Uhr
0
https://www.surgicalroboticstechnology.com/news/new-clinical-studies-show-benefits-of-accuray-cyberknife-in-treatment-of-neurological-indications/
MrTraxxas,
12.07.2022 17:18 Uhr
0
Sau 👍
Summer.76,
12.07.2022 15:49 Uhr
0
Accuray CyberKnife® System Real World Data and Clinical Studies Show Benefits in Treatment of Neurological
https://www.prnewswire.com/news-releases/accuray-cyberknife-system-real-world-data-and-clinical-studies-show-benefits-in-treatment-of-neurological-indications-301583528.html
Summer.76,
23.06.2022 16:27 Uhr
0
https://www.benzinga.com/quote/ARAY/analyst-ratings
Accuray Price Target Announced at $7.50/Share by B. Riley Securities
Summer.76,
02.06.2022 16:37 Uhr
1
Accuray and Limbus AI Inc. Partner to Leverage Limbus' Innovative AI-driven Technology to Enhance Accuray Adaptive Radiotherapy Solutions
https://www.prnewswire.com/news-releases/accuray-and-limbus-ai-inc-partner-to-leverage-limbus-innovative-ai-driven-technology-to-enhance-accuray-adaptive-radiotherapy-solutions-301559886.html
Partnership will Enable Accuray to Use Limbus' Technology to Streamline the Treatment Planning Process and Increase Operational Efficiency
Summer.76,
10.05.2022 16:24 Uhr
0
New Data Presented at ESTRO 2022 Reinforce Benefits of Accuray CyberKnife® and TomoTherapy® Platforms Across a Range of Indications and Complexities
https://www.prnewswire.com/news-releases/new-data-presented-at-estro-2022-reinforce-benefits-of-accuray-cyberknife-and-tomotherapy-platforms-across-a-range-of-indications-and-complexities-301543379.html
More Than 70 Abstracts Build on the Clinical Evidence Supporting the Use of These Technologies
Summer.76,
05.05.2022 15:50 Uhr
1
Accuray ClearRT™ Helical Fan-Beam kVCT Imaging Wins "Best New Technology Solution for Oncology" MedTech Breakthrough Award
https://www.prnewswire.com/news-releases/accuray-clearrt-helical-fan-beam-kvct-imaging-wins-best-new-technology-solution-for-oncology-medtech-breakthrough-award-301540539.html
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies
Summer.76,
27.04.2022 22:17 Uhr
0
https://investors.accuray.com/news-releases/news-release-details/accuray-announces-suzanne-winter-president-promoted-president
Summer.76,
27.04.2022 22:08 Uhr
0
Accuray Reports Fiscal 2022 Third Quarter Financial Results
https://www.prnewswire.com/news-releases/accuray-reports-fiscal-2022-third-quarter-financial-results-301533954.html
Summer.76,
21.04.2022 17:02 Uhr
0
https://www.prnewswire.com/news-releases/owner-of-arkansas-derby-winner-named-horse-after-the-life-changing-accuray-cyberknife-radiation-therapy-technology-used-to-treat-his-cancer-301529800.html
Summer.76,
31.03.2022 16:49 Uhr
1
10-Year Data Shows Accuray CyberKnife® System Provides Long-Lasting Relief of the Excruciating Pain Caused by Trigeminal Neuralgia
https://www.biospace.com/article/releases/10-year-data-shows-accuray-cyberknife-system-provides-long-lasting-relief-of-the-excruciating-pain-caused-by-trigeminal-neuralgia/
Summer.76,
08.03.2022 17:24 Uhr
1
CARTI Selects Accuray CyberKnife® S7™ System to Increase Access to Advanced Cancer Care for Patients in Rural Communities Throughout Arkansas
CARTI is First in Arkansas to Treat Patients with World's Only Robotic Radiosurgery System
https://www.prnewswire.com/news-releases/carti-selects-accuray-cyberknife-s7-system-to-increase-access-to-advanced-cancer-care-for-patients-in-rural-communities-throughout-arkansas-301497478.html
Summer.76,
15.02.2022 15:50 Uhr
1
https://www.prnewswire.com/news-releases/largest-hospital-in-queensland-australia-acquires-multiple-accuray-radixact-systems-with-the-clearrt-helical-fan-beam-kvct-imaging-and-synchrony-technologies-301481340.html
Summer.76,
10.02.2022 15:29 Uhr
0
https://www.benzinga.com/node/25532597
Summer.76,
27.01.2022 5:26 Uhr
0
Accuray GAAP EPS of $0.00 in-line, revenue of $116.28M beats by $13.35M
https://seekingalpha.com/news/3792078-accuray-gaap-eps-of-0_00-in-line-revenue-of-116_28m-beats-13_35m
FQ2 GAAP EPS of $0.00 in-line.
Revenue of $116.28M (+19.3% Y/Y) beats by $13.35M.
Gross orders of $85.4 million, an increase of 13 percent compared to the prior year.
Revising guidance 2022: Total revenue is being increased to an expected range of $420.0 million to $430.0 million compared to the prior range of $420.0 million to $427.0 million, representing a year-over-year growth at the midpoint of the range of 7%. Adjusted EBITDA is now expected to range between $15.0 million to $20.0 million compared to the prior range of $33.0 million to $35.0 million.
Summer.76,
27.01.2022 5:26 Uhr
0
Accuray Reports Fiscal 2022 Second Quarter Financial Results
https://finance.yahoo.com/news/accuray-reports-fiscal-2022-second-210500213.html
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | ATOS Hauptdiskussion | +14,29 % | |
2 | NVIDIA Hauptdiskussion | +3,44 % | |
3 | MicroStrategy | -4,24 % | |
4 | DPCM Capital Hauptdiskussion | +22,62 % | |
5 | Trading- und Aktien-Chat | ||
6 | Novo Nordisk nach Split | +2,42 % | |
7 | TESLA MOTORS Hauptdiskussion | +3,06 % | |
8 | Dax Prognose | -0,02 % | |
9 | Nio für normale Kommunikation | -0,26 % | |
10 | Forum für Leute, die wirklich Interesse an Intellabridge (Kash 2.0) haben! | +128,00 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | ATOS Hauptdiskussion | +14,29 % | |
2 | NVIDIA Hauptdiskussion | +3,15 % | |
3 | MicroStrategy | -4,24 % | |
4 | DPCM Capital Hauptdiskussion | +24,54 % | |
5 | TESLA MOTORS Hauptdiskussion | +2,45 % | |
6 | Novo Nordisk nach Split | +2,42 % | |
7 | Nio für normale Kommunikation | -0,26 % | |
8 | ROCK TECH LITHIUM Hauptdiskussion | +13,04 % | |
9 | TILRAY INC. CL.2 DL-,0001 Hauptdiskussion | +14,34 % | |
10 | Forum für Leute, die wirklich Interesse an Intellabridge (Kash 2.0) haben! | +128,00 % | Alle Diskussionen |